Your Location:
Home >
Browse articles >
Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway
Updated:2026-04-30
Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 11, Pages: 1-12(2026)
DOI: 10.13422/j.cnki.syfjx.20251904
Revised:2025-10-31 ,
Accepted:24 November 2025
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 6 )
References
Publication Info
Metrics
321
Views
176
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Effect Difference and Mechanisms of Zishenwan Against Chronic Prostatitis Before and After Salt-processing of Anemarrhenae Rhizoma and Phellodendri Chinensis Cortex by Integrating Network Pharmacology and Metabolomics
Bioinformatics Reveals Mechanism of Zuoguiwan in Treating Polycystic Ovary Syndrome
Exploration of Material Basis of "Clearing Excessive Fire of Liver-gallbladder" of Bile-processed Coptidis Rhizoma Based on UPLC-Q-TOF/MS Metabolomics and Molecular Docking Technology
Expert Consensus on Clinical Application of SkinPro Ointment
Related Author
XIANG Jiao
LUO Jieying
LIAO Daiyuan
LI Fulai
YI Rui
LIANG Yong
MO Zunhui
LIU Dongyan
Related Institution
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
Key Laboratory of Chinese Medicine Germplasm Resources Innovation and Effective Uses in Sichuan Province,School of Pharmacy,School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine
School of Life Science and Engineering,Southwest Jiaotong University


